Russell Investments »

Halozyme Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 360k 36.96
2023-09-30 $16M 423k 38.20
2023-06-30 $6.3M 174k 36.07
2023-03-31 $7.9M 207k 38.19
2022-12-31 $14M 242k 56.90
2022-09-30 $11M 271k 39.54
2022-06-30 $12M 273k 43.99
2022-03-31 $6.4M 161k 39.87
2021-12-31 $2.7M 68k 40.19
2021-09-30 $3.1M 76k 40.68
2021-06-30 $4.1M 90k 45.39
2021-03-31 $8.9M 215k 41.68
2020-12-31 $8.3M 195k 42.69
2020-09-30 $5.3M 201k 26.23
2020-06-30 $4.5M 167k 26.77
2020-03-31 $2.4M 133k 17.94
2019-12-31 $1.9M 106k 17.65
2019-09-30 $1.5M 98k 15.49
2019-06-30 $2.4M 143k 17.17
2019-03-31 $3.5M 220k 16.09
2018-12-31 $3.4M 236k 14.61
2018-09-30 $3.5M 191k 18.16
2018-06-30 $3.0M 179k 16.88
2018-03-31 $6.6M 336k 19.59
2017-12-31 $12M 563k 20.71
2017-09-30 $2.3M 132k 17.37
2017-06-30 $1.6M 128k 12.82
2017-03-31 $486k 38k 12.95
2016-12-31 $602k 61k 9.94